Biotechnology | CDC | Diagnostics | Disease
Michigan reports the first 2 US deaths related to a diarrhea-causing parasite
On Aug. 3, 2026, Michigan, state health officials announced that two people have died in the cyclospora outbreak,…
-
-
Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
Biotechnology | Imaging | Medical Device | Neurology | Non-Profit Research | Oncology | Therapeutics
UVA Radiology Professors Develop New Focused Ultrasound Approach for Brain Tumors
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
-
patient receives pioneering lung cancer vaccine in World First
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
-
Biotechnology | CDMO | CMO | Medical Device
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
On Jul. 30, 2026, Resilience, a technology-forward contract development and manufacturing organization dedicated to broadening access to complex…
-
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
On Jul. 29, 2026, the U.S. Food and Drug Administration (FDA) announced it has licensed Ezplaz Freeze Dried…
-
USDA to fund Arizona facility to fight flesh-eating livestock pest
On Jul. 29, 2026, the U.S. Department of Agriculture (USDA) announced it will spend $25 million on a…
-
Biotechnology | Diagnostics | FDA | Oncology
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
-
Agriculture | Biotechnology | CDC | Diagnostics | Disease | FDA
Michigan reports 9,253 cyclosporiasis cases as infection outbreak expands
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
-
Argenx to Acquire Forte Biosciences for $2.2 billion
On Jul. 27, 2026, argenx, a global immunology innovation company, and Dallas-based Forte Biosciences announced that the companies…
-
Ebola infections in DR Congo surge to 3,200, with 1,405 deaths
On Jul. 27, 2026, the number of people infected with Ebola in the Democratic Republic of the Congo…
-
Blood Proteins May Predict When Genetically At-Risk People Develop ALS
On Jul. 27, 2026, an international research team led by University of Miami Miller School of Medicine scientists…
-
Chinese researchers achieve breakthrough in hybrid rice cloning
On Jul. 26, 2026, Chinese researchers announced they have achieved a major breakthrough in the cloning of hybrid…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | NIH | Vaccine
The US Reports More measles cases this year than in all of 2025
On Jul. 24, 2026, the number of measles cases in the U.S. surpassed the record-breaking tally for all…
-
US CDC links four more states to cyclosporiasis outbreak, Washington Post reports
On Jul. 24, 2026, The U.S. Centers for Disease Control and Prevention has linked four additional states to…
-
Biotechnology | Disease | HIV | Therapeutics | WHO
Merck licenses experimental HIV pill to generic makers in 129 countries
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
U.S. FDA investigates another cyclosporiasis outbreak
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
-
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
On Jul. 21, 2026, OraSure Technologies announced that it has received Emergency Use Authorization (EUA) from the U.S….
-
Tempus to Acquire Personalis for $1.5 Billion
On Jul. 20, 2026, Tempus AI, a technology company leading the adoption of AI to advance precision medicine…
-
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
-
Scientists map how the flu virus rewires the human cell from the inside
On Jul. 20, 2026, researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology…
-
Researchers Generate red blood cell-like cells from canine iPSCs
On Jul. 20, 2026, a research group led by Osaka Metropolitan University (OMU) using dog iPS cells announced…
-
Samsung Biologics announces all-cash offer to acquire PolyPeptide for CHF 1.46 billion, expanding global network across U.S., Europe, and India
On Jul. 19, 2026, Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100%…
-
Feinstein Institutes technology that restores movement and sensation after paralysis Published in Nature Medicine
On Jul. 16, 2026, the Feinstein Institutes for Medical Research announced findings featured in Nature Medicine demonstrating that…
-
Lilly to acquire AtaiBeckley for $3.8 billion advancing therapies for treatment-resistant depression
On Jul. 16, 2026, Eli Lilly and AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health…
-
Merck’s LIPFENDRA® (enlicitide) Approved by the FDA to Reduce Cholesterol
On Jul. 16, 2026, Merck announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA® (enlicitide) tablets…
-
Protein Walks on Legs to Keep Our Nerve Cells Alive
On Jul. 15, 2026, a University of California, Davis (UC Davis) led study have unveiled a new structure…
-
50,000-year-old DNA from South African antelope rewrites limits of ancient DNA preservation
On Jul. 15, 2026, scientists announced recovering ancient DNA from a 50,000-year-old antelope tooth found in South Africa,…
-
FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
